Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries ZyVersa Therapeutics, Inc. - Common Stock (NQ: ZVSA ) 3.370 +0.120 (+3.69%) Streaming Delayed Price Updated: 3:59 PM EDT, Aug 6, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about ZyVersa Therapeutics, Inc. - Common Stock < Previous 1 2 3 4 5 6 7 Next > ZyVersa Therapeutics Announces a Publication in Journal of the American Heart Association Linking NLRP3 Inflammasomes with Calcification in Arteries of Patients with Peripheral Arterial Disease (PAD) June 20, 2023 From ZyVersa Therapeutics Via GlobeNewswire Stocks That Hit 52-Week Lows On Thursday June 15, 2023 On Thursday, 64 companies achieved new lows for the year. Via Benzinga Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session June 15, 2023 Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396. Via Benzinga ZyVersa Therapeutics Publishes New White Paper Detailing the Critical Role of Inflammasome ASC in Inflammatory Diseases, and Its Potential as a Therapeutic Target June 13, 2023 From ZyVersa Therapeutics Via GlobeNewswire European Patent Office to Grant ZyVersa Therapeutics’ Patent Application for Cholesterol Transport Mediator™ VAR 200 for Use in Patients with Diabetic Nephropathy/Diabetic Kidney Disease June 06, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics Announces a Publication in Frontiers in Medicine Showing Direct Inflammasome Activation in Children with Juvenile Idiopathic Arthritis May 25, 2023 From ZyVersa Therapeutics Via GlobeNewswire Why Immix Biopharma Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket May 22, 2023 Gainers SeqLL Inc. (NASDAQ: SQL) shares surged 61.1% to $0.54 in pre-market trading after dropping 14% on Friday. SeqLL recently posted a wider first-quarter loss. Via Benzinga Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session May 22, 2023 Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday May 22, 2023 We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday! Via InvestorPlace ZyVersa Therapeutics Announces Changes to ZyVersa’s Board of Directors May 19, 2023 From ZyVersa Therapeutics Via GlobeNewswire Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 19, 2023 Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares climbed 148.3% to $29.18 after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of 2,374,641 shares of its... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session May 19, 2023 Via Benzinga Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket May 19, 2023 Gainers Monogram Orthopaedics Inc. (NASDAQ: MGRM) shares surged 163.7% to $30.98 in pre-market trading after jumping 62% on Thursday. Monogram Orthopaedics raised $17,216,147 through the sale of... Via Benzinga ZyVersa Therapeutics Announces Article Published in Metabolism Pointing to Glomerular Cholesterol Accumulation as Key Factor Exacerbating Renal Injury and Dysfunction in Diabetic Kidney Disease May 15, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics Reports First Quarter 2023 Corporate and Financial Results May 12, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in A.G.P.’s Virtual Healthcare Conference May 11, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2023 BIO International Convention May 09, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics Announces a Publication in Hepatology Revealing That Alcohol-induced Extracellular ASC Specks Perpetuate Liver Inflammation and Damage in Alcoholic Hepatitis May 04, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering May 01, 2023 From ZyVersa Therapeutics Via GlobeNewswire ZyVersa Therapeutics' CEO, Stephen C. Glover, to Present at Sidoti Micro-Cap Virtual Conference April 27, 2023 From ZyVersa Therapeutics Via GlobeNewswire Crude Oil Down 3%; Boeing Reports Better-Than-Expected Sales April 26, 2023 U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 150 points on Wednesday. The Dow traded down 0.49% to 33,366.74 while the NASDAQ rose 0.75% to 11,887.81. The S&P... Via Benzinga Stocks That Hit 52-Week Lows On Wednesday April 26, 2023 On Wednesday, 345 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session April 26, 2023 Via Benzinga Why Chipotle Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session April 26, 2023 Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) shares jumped 105% to $0.1730 after the company issued a letter to shareholders. Via Benzinga Dow Edges Lower; Alphabet Posts Upbeat Results April 26, 2023 U.S. stocks traded mixed midway through trading, with the Dow Jones turning lower on Wednesday. The Dow traded down 0.11% to 33,492.84 while the NASDAQ rose 1.16% to 11,936.00. The S&P 500, also rose,... Via Benzinga Why Is Enphase Energy (ENPH) Stock Down 19% Today? April 26, 2023 Enphase Energy (ENPH) stock is falling hard on Wednesday following the release of its earnings report for the first quarter of 2023. Via InvestorPlace ZyVersa Therapeutics, Inc. Announces Pricing of $11.0 Million Public Offering April 26, 2023 From ZyVersa Therapeutics Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 26, 2023 Via Benzinga Why Is Bed Bath & Beyond (BBBY) Stock Down 24% Today? April 26, 2023 Bed Bath & Beyond (BBBY) stock is falling on Wednesday as the company's recent bankruptcy announcement weighs on its shares. Via InvestorPlace Why Is ZyVersa Therapeutics (ZVSA) Stock Down 46% Today? April 26, 2023 ZyVersa Therapeutics (ZVSA) stock is sliding lower on Wednesday following a couple of announcements from the biopharmaceutical company. Via InvestorPlace < Previous 1 2 3 4 5 6 7 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.